KR101226121B1 - 디클로페낙 및 그의 약학적으로 허용가능한 염의 주사 가능제제 - Google Patents

디클로페낙 및 그의 약학적으로 허용가능한 염의 주사 가능제제 Download PDF

Info

Publication number
KR101226121B1
KR101226121B1 KR1020077019888A KR20077019888A KR101226121B1 KR 101226121 B1 KR101226121 B1 KR 101226121B1 KR 1020077019888 A KR1020077019888 A KR 1020077019888A KR 20077019888 A KR20077019888 A KR 20077019888A KR 101226121 B1 KR101226121 B1 KR 101226121B1
Authority
KR
South Korea
Prior art keywords
water
diclofenac
solvent
alcohol
propylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020077019888A
Other languages
English (en)
Korean (ko)
Other versions
KR20070107091A (ko
Inventor
케탄 라지니브하이 파텔
밀란 라지니브하이 파텔
Original Assignee
트로이카 파마슈티칼스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36953757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101226121(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 트로이카 파마슈티칼스 리미티드 filed Critical 트로이카 파마슈티칼스 리미티드
Publication of KR20070107091A publication Critical patent/KR20070107091A/ko
Application granted granted Critical
Publication of KR101226121B1 publication Critical patent/KR101226121B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020077019888A 2005-02-01 2006-01-30 디클로페낙 및 그의 약학적으로 허용가능한 염의 주사 가능제제 Expired - Fee Related KR101226121B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN96MU2005 2005-02-01
IN96/MUM/2005 2005-02-01
PCT/IN2006/000033 WO2006095363A2 (en) 2005-02-01 2006-01-30 Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Publications (2)

Publication Number Publication Date
KR20070107091A KR20070107091A (ko) 2007-11-06
KR101226121B1 true KR101226121B1 (ko) 2013-01-25

Family

ID=36953757

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077019888A Expired - Fee Related KR101226121B1 (ko) 2005-02-01 2006-01-30 디클로페낙 및 그의 약학적으로 허용가능한 염의 주사 가능제제

Country Status (20)

Country Link
US (1) US8809393B2 (enExample)
EP (1) EP1848419B1 (enExample)
JP (1) JP2008528572A (enExample)
KR (1) KR101226121B1 (enExample)
CN (1) CN101123957B (enExample)
AP (1) AP2888A (enExample)
AU (2) AU2006221633B2 (enExample)
BR (1) BRPI0606119B8 (enExample)
CA (1) CA2596031C (enExample)
DK (1) DK1848419T3 (enExample)
EA (1) EA013616B1 (enExample)
ES (1) ES2392097T3 (enExample)
IL (1) IL184697A (enExample)
MX (1) MX2007009312A (enExample)
NZ (1) NZ554779A (enExample)
PL (1) PL1848419T3 (enExample)
PT (1) PT1848419E (enExample)
UA (1) UA93365C2 (enExample)
WO (1) WO2006095363A2 (enExample)
ZA (1) ZA200705729B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009155315A (ja) * 2007-12-26 2009-07-16 Fujiyakuhin Co Ltd 注射剤
WO2013005226A1 (en) * 2011-07-04 2013-01-10 Zota Health Care Ltd A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103432132B (zh) * 2013-08-31 2015-01-21 西南大学 甲磺酸普立地诺双氯芬酸钠注射液及其制备方法
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157928A1 (en) 2003-02-12 2004-08-12 Jae-Hwan Kim Solvent system of hardly soluble drug with improved dissolution rate
KR20040073255A (ko) * 2003-02-12 2004-08-19 알앤피코리아주식회사 용출률이 향상된 난용성 약제의 용매 시스템 및 이를함유한 제약학적 제제

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200488L (sv) 1982-01-29 1983-07-30 Svenska Flaektfabriken Ab Arreteringsanordning, serskilt for forankring av till- och franluftventiler i ventilationskanaler
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
ATE164080T1 (de) * 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US5554650A (en) * 1994-07-28 1996-09-10 Southern Research Institute Antiphlogistic, analgesic, antipyretic injection preparation
GB9502695D0 (en) 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
WO1997049411A1 (en) * 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US5853263A (en) * 1996-08-15 1998-12-29 Accrued, Inc. System for installing raised road markers
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE10105576C1 (de) * 2001-02-07 2002-08-08 Underberg Kg Flasche mit im Boden ausgebildeten Griffmulden
IN192711B (enExample) 2002-01-22 2004-05-15 Ketan Rajnibhai Patel
CH694034A8 (de) * 2002-12-12 2004-08-31 Mepha Ag Diclofenac-Kalium-Injektionsloesung.
CN1557290A (zh) 2004-01-19 2004-12-29 江苏扬子江药业集团有限公司 复方双氯芬酸钾注射液制剂
AU2004317520B2 (en) 2004-03-10 2011-06-09 Shimoda Biotech (Pty) Ltd Stable injectable diclofenac compositions
CN1279897C (zh) 2004-04-30 2006-10-18 济南百诺医药科技开发有限公司 含有双氯芬酸盐和利多卡因的冻干制剂及其制备方法
ITMI20041245A1 (it) 2004-06-22 2004-09-22 Ibsa Inst Biochimique Sa Composizioni farmaceutiche iniettabnili comprendenti diclofenac sodico e b-ciclodestrina

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157928A1 (en) 2003-02-12 2004-08-12 Jae-Hwan Kim Solvent system of hardly soluble drug with improved dissolution rate
KR20040073255A (ko) * 2003-02-12 2004-08-19 알앤피코리아주식회사 용출률이 향상된 난용성 약제의 용매 시스템 및 이를함유한 제약학적 제제

Also Published As

Publication number Publication date
US20080153914A1 (en) 2008-06-26
BRPI0606119B8 (pt) 2021-05-25
NZ554779A (en) 2011-02-25
DK1848419T3 (da) 2012-11-05
PL1848419T3 (pl) 2012-12-31
BRPI0606119A2 (pt) 2009-06-02
CA2596031A1 (en) 2006-09-14
EP1848419B1 (en) 2012-07-25
CN101123957A (zh) 2008-02-13
MX2007009312A (es) 2008-03-10
UA93365C2 (ru) 2011-02-10
AU2009233594A1 (en) 2009-11-19
WO2006095363A2 (en) 2006-09-14
ES2392097T3 (es) 2012-12-04
IL184697A0 (en) 2007-12-03
CA2596031C (en) 2013-02-19
CN101123957B (zh) 2010-12-08
WO2006095363A3 (en) 2006-12-14
EA200701645A1 (ru) 2008-02-28
KR20070107091A (ko) 2007-11-06
AU2006221633B2 (en) 2009-07-30
JP2008528572A (ja) 2008-07-31
EA013616B1 (ru) 2010-06-30
IL184697A (en) 2014-02-27
US8809393B2 (en) 2014-08-19
AP2007004101A0 (en) 2007-08-31
PT1848419E (pt) 2012-10-31
EP1848419A2 (en) 2007-10-31
WO2006095363B1 (en) 2007-02-01
BRPI0606119B1 (pt) 2019-05-07
AU2006221633A1 (en) 2006-09-14
ZA200705729B (en) 2008-08-27
AP2888A (en) 2014-05-31

Similar Documents

Publication Publication Date Title
DK175662B1 (da) Blandingsmicelleoplösninger med ikke-steroide inflammationshæmmmere
JP6117939B2 (ja) ジクロフェナク組成物
PT79656B (en) Process for preparing a non-aqueous ivermectin formulation with improved antiparasitic activity
AU2009233594A1 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
WO1998052612A1 (fr) Composition antiseptique
US20170119794A1 (en) Treatments of accumulated fat with deoxycholic acid and salts thereof
ES2843723T3 (es) Formulaciones farmacéuticas inyectables de lefamulina
AU2006250765A1 (en) Injectable compositions and process for preparation of such compositions
US9211251B2 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
WO2016170401A1 (en) Novel injectable composition of diclofenac sodium
AU711856B2 (en) Combination injection preparation
RU2162699C1 (ru) Водно-дисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов
RU2282437C1 (ru) Средство для лечения болезней суставов

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20151228

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20161221

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20171227

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20180927

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20190923

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20240119

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20240119